Filtros : "HEPATOPATIAS" "México" Removido: "2004" Limpar

Filtros



Limitar por data


  • Fonte: Archives of Medical Research. Unidade: FM

    Assuntos: FÍGADO GORDUROSO, INIBIDORES DE ENZIMAS, HEPATOPATIAS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ONI, Ebenezer T. et al. Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease. Archives of Medical Research, v. 45, n. 1, p. 52-57, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.arcmed.2013.12.003. Acesso em: 27 dez. 2024.
    • APA

      Oni, E. T., Sinha, P., Karim, A., Martin, S. S., Blaha, M. J., Agatston, A. S., et al. (2014). Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease. Archives of Medical Research, 45( 1), 52-57. doi:10.1016/j.arcmed.2013.12.003
    • NLM

      Oni ET, Sinha P, Karim A, Martin SS, Blaha MJ, Agatston AS, Blumenthal RS, Meneghelo RS, Conceiçao RD, Santos RD, Nasir K. Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease [Internet]. Archives of Medical Research. 2014 ; 45( 1): 52-57.[citado 2024 dez. 27 ] Available from: https://doi.org/10.1016/j.arcmed.2013.12.003
    • Vancouver

      Oni ET, Sinha P, Karim A, Martin SS, Blaha MJ, Agatston AS, Blumenthal RS, Meneghelo RS, Conceiçao RD, Santos RD, Nasir K. Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease [Internet]. Archives of Medical Research. 2014 ; 45( 1): 52-57.[citado 2024 dez. 27 ] Available from: https://doi.org/10.1016/j.arcmed.2013.12.003
  • Fonte: Annals of Hepatology. Unidade: FCF

    Assuntos: HEPATITE C, HEPATITE CRÔNICA, HEPATOPATIAS

    Acesso à fonteComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VIANA, Mônica Salum Valverde Borsoi et al. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. Annals of Hepatology, v. 8, n. 1, p. 26-31, 2009Tradução . . Disponível em: http://www.medigraphic.com/pdfs/hepato/ah-2009/ah091g.pdf. Acesso em: 27 dez. 2024.
    • APA

      Viana, M. S. V. B., Takei, K., Yamaguti, D. C. C., Guz, B., & Strauss, E. (2009). Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C. Annals of Hepatology, 8( 1), 26-31. Recuperado de http://www.medigraphic.com/pdfs/hepato/ah-2009/ah091g.pdf
    • NLM

      Viana MSVB, Takei K, Yamaguti DCC, Guz B, Strauss E. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C [Internet]. Annals of Hepatology. 2009 ; 8( 1): 26-31.[citado 2024 dez. 27 ] Available from: http://www.medigraphic.com/pdfs/hepato/ah-2009/ah091g.pdf
    • Vancouver

      Viana MSVB, Takei K, Yamaguti DCC, Guz B, Strauss E. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C [Internet]. Annals of Hepatology. 2009 ; 8( 1): 26-31.[citado 2024 dez. 27 ] Available from: http://www.medigraphic.com/pdfs/hepato/ah-2009/ah091g.pdf

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024